Literature DB >> 19322585

A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland.

Hong He1, Guanfu Chen, Liang Zhou, Yanmin Liu.   

Abstract

OBJECTIVE: To detect the levels of carcinoembryonic antigen (CEA) and carcinoma associated antigen CA-50 in the patients with oral or salivary malignant tumors.
METHODS: The concentrations of salivary CEA and CA-50 were assayed in 80 patients of oral and salivary malignant tumors, 40 patients of benign tumors and 80 health controls. In 80 patients with malignant tumors, serum CEA and CA-50 were also assayed by enzyme-linked immunoabsorbent assay and immunoradiometric analysis, respectively.
RESULTS: Salivary CEA and CA-50 levels were significantly higher in malignant tumors than in benign tumors and in health controls, respectively (P < 0.001). Only 7 cases and 3 cases of 80 patients with malignant tumors were found having increased serum CEA and CA-50 levels, respectively.
CONCLUSIONS: The measurement of CEA and CA-50 levels in saliva were more sensitive than in serum. This may be more useful as prognostic indicators in early diagnosis of oral and salivary malignant tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322585     DOI: 10.1007/s00432-009-0572-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  17 in total

1.  The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA.

Authors:  N Duraker; A N Celik
Journal:  J Surg Oncol       Date:  2001-04       Impact factor: 3.454

2.  Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer.

Authors:  D Marrelli; E Pinto; A De Stefano; G de Manzoni; M Farnetani; L Garosi; F Roviello
Journal:  J Surg Oncol       Date:  2001-12       Impact factor: 3.454

3.  Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA 242 during twelve months in men and women aged 60-64 years without malignant disease.

Authors:  B Engarås; L Hafström; J Kewenter; O Nilsson; H Wedel
Journal:  Eur J Surg       Date:  1999-02

4.  Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients.

Authors:  D Y Kim; H R Kim; J H Shim; C S Park; S K Kim; Y J Kim
Journal:  J Surg Oncol       Date:  2000-07       Impact factor: 3.454

5.  Radioimmunological and immunohistochemical study of carcinoembryonic antigen in pleomorphic adenoma and mucoepidermoid carcinoma of the salivary glands.

Authors:  A Angelov; A Klissarova; K Dikranian
Journal:  Gen Diagn Pathol       Date:  1996-03

6.  Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients.

Authors:  Hiroshi Koike; Daisuke Ichikawa; Hisashi Ikoma; Eigo Otsuji; Kazuya Kitamura; Hisakazu Yamagishi
Journal:  J Surg Oncol       Date:  2004-09-15       Impact factor: 3.454

Review 7.  Cytokeratin fragments in the serum: their utility for the management of oral cancer.

Authors:  Sharada S Sawant; Surekha M Zingde; Milind M Vaidya
Journal:  Oral Oncol       Date:  2008-01-18       Impact factor: 5.337

8.  Glycoprotein tumour markers in head and neck neoplasms--a consecutive study on CA-50, CA 19-9, and CEA.

Authors:  H Gustafsson; L Franzén; K Grankvist; M Anniko; R Henriksson
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  Tumor-associated antigens are cytokine inducers and hyporeactivity factors to the immune system.

Authors:  A D Inglot; F Gelder; J A Georgiades
Journal:  Biotherapy       Date:  1998

10.  CEA levels in serum and BAL in patients suffering from lung cancer: correlation with individuals presenting benign lung lesions and healthy volunteers.

Authors:  Konstantinos Charalabopoulos; Agathi Karakosta; George Bablekos; Christos Golias; Alexandros Charalabopoulos; Eleni Tsanou; Dimitrios Peschos; Leonidas Zoganas; Anna Batistatou
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

View more
  3 in total

1.  A review of research on salivary biomarkers for oral cancer detection.

Authors:  Yi-Shing Lisa Cheng; Terry Rees; John Wright
Journal:  Clin Transl Med       Date:  2014-02-24

2.  Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.

Authors:  Éva Csősz; Péter Lábiscsák; Gergő Kalló; Bernadett Márkus; Miklós Emri; Adrienn Szabó; Ildikó Tar; József Tőzsér; Csongor Kiss; Ildikó Márton
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

3.  Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.

Authors:  Jana Karbanová; Jan Laco; Anne-Marie Marzesco; Peggy Janich; Magda Voborníková; Jaroslav Mokrý; Christine A Fargeas; Wieland B Huttner; Denis Corbeil
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.